We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
As with all products, we will keep its safety under close review
Defence scientists develop glue that enables rapid repairs to equipment in extreme environments.
Product Recall for 3M Face Shield presenting a risk of kinetic energy/high-speed flying particles.
Summary of the latest safety advice for medicines and medical device users
Advice for medical professionals to follow when assessing drivers with diabetes mellitus.
Product Recall for 3M™ 5E 11 Face Shield presenting a risk of damage to sight.
Part of the Department of Health’s Healthcare Associated Infections Technology Innovation Programme.
Semaglutide is the first weight loss drug approved in the UK as a preventative treatment for those with established cardiovascular disease
These reports explain our assessment of the scientific evidence used to lead to regulatory decisions on the safety of medicines or medicines classes.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).